scholarly journals Delayed coronary obstruction of the left main artery after transcatheter aortic valve replacement

2020 ◽  
Vol 92 (4) ◽  
pp. 70-75
Author(s):  
A. E. Komlev ◽  
P. M. Lepilin ◽  
E. V. Kurilina ◽  
V. V. Romakina ◽  
T. E. Imaev

Coronary arteries obstruction associated with transcatheter aortic valve implantation (TAVI) may occur either during the procedure or after it. In the latter coronary obstruction can be further divided into early (7 days after procedure) or delayed one (7 days). Delayed coronary obstruction (DCO) is referred as a rare but devastating complication after TAVI and is associated with the extremely high mortality. This case demonstrates the objective difficulties of timely diagnostics of DCO. Since the results of non-invasive methods are indetermined in most cases, the authors conclude that even low-specific clinical symptoms must be interpreted as the definite rationale for the implementation of invasive diagnostic and treatment strategy.

2016 ◽  
Vol 43 (5) ◽  
pp. 441-445 ◽  
Author(s):  
Tsuyoshi Isawa ◽  
Norio Tada ◽  
Tatsushi Ootomo

Coronary obstruction during or after transcatheter aortic valve replacement is a rare and catastrophic sequela that occurs most frequently just after valve implantation. Even rarer is the delayed clinical presentation, in some few patients, of coronary obstruction on the day after self-expandable valve implantation. Here we describe a case of balloon-expandable (not self-expandable) transcatheter aortic valve replacement, followed by partial obstruction of the left main coronary artery on the day after that procedure in a 93-year-old man, despite normal left ventricular contraction just after valve implantation. Visual evaluation of the echocardiogram for left ventricular wall motion was not sufficient, by itself, to achieve early diagnosis of the obstruction. We performed emergency percutaneous coronary intervention. Ninety days after the procedure, the patient was in New York Heart Association functional class I.


2016 ◽  
Vol 31 (5) ◽  
pp. 315-317 ◽  
Author(s):  
Gilbert H. L. Tang ◽  
Hasan Ahmad ◽  
Martin Cohen ◽  
Cenap Undemir ◽  
Steven L. Lansman

2020 ◽  
pp. 49-57
Author(s):  
Giovanni Esposito ◽  
Anna Franzone

L’impianto transcatetere di valvola aortica (Transcatheter Aortic Valve Replacement, TAVI) è una procedura di cardiologia interventistica, introdotta nel 2002, che prevede il posizionamento e l’impianto di una protesi biologica a livello dell’annulus aortico mediante accesso percutaneo, prevalentemente transfemorale. Dopo le prime esperienze cliniche, riservate a pazienti senza altre opzioni terapeutiche, la TAVI si è affermata come alternativa all’intervento chirurgico tradizionale di sostituzione valvolare grazie ad una serie di studi randomizzati che ne hanno dimostrato l’efficacia e la sicurezza in pazienti appartenenti a tutto lo spettro del rischio operatorio (da estremo a basso). L’utilizzo della TAVI è in continua crescita, a livello mondiale, e si assiste ad una progressiva espansione delle sue indicazioni cliniche (stenosi di valvola bicuspide, insufficienza aortica severa). Il presente articolo ha lo scopo di riassumere i recenti progressi nell’ambito del trattamento transcatetere della stenosi valvolare aortica, descrivere le caratteristiche della procedura e analizzare i risultati degli studi che ne hanno favorito la diffusione nella pratica clinica.


Author(s):  
Gabriel Kanhouche ◽  
Felipe Reale Cividanes ◽  
Roney Orismar Sampaio ◽  
José Carlos Albuquerque da Silva ◽  
Rodrigo Daghlawi Machado ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document